Tag: Therapeutics

We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ranks ...

Riding the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a ...

NMRA|EPS -$0.35|Net Loss $59.4M Neumora Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for brain diseases. Based ...

Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s ...

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news MindBio Therapeutics ...

Loss Per Share (GAAP) $0.26 Loss narrows sharply. Dogwood Therapeutics, Inc. (NASDAQ: DWTX) reported a loss of $0.26 per share ...

Soleno Therapeutics (NASDAQ:SLNO) is one of the 17 biotechnology stocks with more than 50% upside. On January 20, the price ...

Follow us on Google for the latest stock news The US FDA has issued a Complete Response Letter to Outlook ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the “Contrarius Global Equity Fund”. A copy ...

Israeli biopharmaceutical company Syremis Therapeutics, which is developing medicines for mental health conditions, has announced the completion of a ...